SMTL ID : 3qwo.2 (1 other biounit)

Crystal structure of a motavizumab epitope-scaffold bound to motavizumab Fab

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 4 residues within 4Å: Chain A: Q.36, K.38, K.41, K.44 3 PLIP interactions: 3 interactions with chain A Salt bridges: A:K.38, A:K.41, A:K.44

2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.2: 10 residues within 4Å: Chain A: Q.36, K.38, K.44, L.46, V.57, P.58, R.60, F.61, D.80, D.81 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:Q.36, A:K.38, A:K.44, A:R.60, A:D.80, A:D.81 EDO.3: 9 residues within 4Å: Chain A: V.132, Q.159, S.161, T.177 Chain B: L.148, V.176, S.184, L.185, S.186 5 PLIP interactions: 3 interactions with chain B, 2 interactions with chain A Hydrogen bonds: B:S.186 Water bridges: B:S.186, B:S.186, A:T.177, A:T.177

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

McLellan, J.S. et al., Design and characterization of epitope-scaffold immunogens that present the motavizumab epitope from respiratory syncytial virus. J.Mol.Biol. (2011)

Release Date

2011-05-04

Peptides

motavizumab light chain: A
motavizumab heavy chain: B
motavizumab epitope scaffold: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

B
A

C
C

motavizumab light chain

motavizumab heavy chain

motavizumab epitope scaffold

Related Entries With Identical Sequence